Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy are one step closer to solving that problem.
Machine learning can help predict patient response to cancer immunotherapy
November 16, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022
Bayer with continued strong performance
November 10, 2022